Table of Contents
Marocaine Ste de Therapeutique (Sothema), Morocco’s leading healthcare company led by Lamia Tazi, has signed a Memorandum of Understanding (MOU) with Mauritania’s Central Purchasing Center for Essential Medicines and Medical Consumables (CAMEC), marking a substantial step towards boosting healthcare efforts in Mauritania.
The MOU, signed by Dr. Sadek Oum Elvadli, general manager of CAMEC, and representatives of Sothema, marks a milestone in strengthening cooperation in the supply of medicines to Mauritania.
The signing ceremony, held at Sothema’s headquarters, brought together prominent figures from both entities, emphasizing their commitment to enhancing public health infrastructure and access to essential medicines in Mauritania.
Sothema CEO, Lamia Tazi champions affordable healthcare access for Arab and African nations
Lamia Tazi, the chairperson and CEO of Sothema, expressed her enthusiasm about the collaboration, emphasizing Sothema’s dedication to supporting friendly Arab and African countries by providing affordable access to the latest therapeutics.
In a LinkedIn post confirming the deal, Tazi stated, “Sothema will always stand by friendly Arab and African countries by making available and affordable the latest therapeutics their patients need.”
Tazi’s leadership has been instrumental in Sothema’s growth and expansion in recent years. As a prominent investor on the Casablanca bourse, Tazi holds a significant 8.4-percent stake in Sothema, amounting to 605,030 issued shares.
Her strategic vision and management acumen have propelled the company to become a key player in the healthcare sector, both domestically and internationally.
Sothema and CAMEC: Collaborative commitment to addressing healthcare challenges in Mauritania
Sothema’s position as Morocco’s premier healthcare company is underscored by its impressive production capacity of approximately 60 million pharmaceutical units per year.
With a diverse portfolio comprising products developed and sold by 35 global laboratories, Sothema serves markets across Europe, the Maghreb, Sub-Saharan Africa, and the Persian Gulf region.
The collaboration between Sothema and CAMEC signifies a commitment to leveraging expertise and resources to address healthcare challenges in Mauritania.
By facilitating the supply of essential medicines and medical consumables, the partnership aims to improve healthcare access and outcomes for the Mauritanian population.
Sothema and CAMEC’s collaborative MOU sparks optimism for healthcare transformation
With Sothema’s track record of excellence in pharmaceutical manufacturing and distribution, coupled with CAMEC’s mandate to ensure access to essential healthcare supplies, the MOU sets the stage for impactful initiatives that will contribute to advancing public health priorities in Mauritania.
Both parties expressed optimism about the collaboration’s potential to make a tangible difference in addressing healthcare needs, underscoring the shared commitment to promoting health and well-being in the region.
As the partnership progresses, stakeholders anticipate positive outcomes that will benefit communities and contribute to broader efforts aimed at advancing healthcare access and delivery in Mauritania.
